Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yulia R Aleksandrova

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Medicinal Chemistry|December 21, 2020
The Hydroxamic Acids as Potential Anticancer and Neuroprotective AgentsMargarita E Neganova, Sergey G Klochkov, Yulia R Aleksandrova, et al.
Seminars in Cancer Biology|August 20, 2020
Histone modifications in epigenetic regulation of cancer: Perspectives and achieved progressMargarita E Neganova, Sergey G Klochkov, Yulia R Aleksandrova, et al.
Seminars in Cancer Biology|July 2, 2022
Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disordersMargarita E Neganova, Yulia R Aleksandrova, Olga A Sukocheva, et al.
Bioorganic & Medicinal Chemistry Letters|August 14, 2022
Synthesis and biological testing of 3,5-bis(arylidene)-4-piperidone conjugates with 2,5-dihydro-5H-1,2-oxaphospholenesMargarita E Neganova, Yulia R Aleksandrova, Natalia S Nikolaeva, et al.
Anti-Cancer Agents in Medicinal Chemistry|May 28, 2020
New Spirocyclic Hydroxamic Acids as Effective Antiproliferative AgentsMargarita E Neganova, Sergey G Klochkov, Yulia R Aleksandrova, et al.
Molecules (Basel, Switzerland)|December 11, 2022
Design of Conjugates Based on Sesquiterpene Lactones with Polyalkoxybenzenes by "Click" Chemistry to Create Potential Anticancer AgentsMargarita E Neganova, Ekaterina V Smirnova, Elena V Sharova, et al.
Seminars in Cancer Biology|May 27, 2022
Perspectives of using microRNA-loaded nanocarriers for epigenetic reprogramming of drug resistant colorectal cancersOlga A Sukocheva, Junqi Liu, Margarita E Neganova, et al.
Molecules (Basel, Switzerland)|November 27, 2024
N-Aryl Benzimidazole and Benzotriazole Derivatives and Their Hybrids as Cytotoxic Agents: Design, Synthesis and Structure-Activity Relationship StudiesYulia R Aleksandrova, Natalia S Nikolaeva, Inna A Shagina, et al.
Current Cancer Drug Targets|April 23, 2020
Synthesis and Cytotoxic Activity of Azine Derivatives of 6-HydroxyxanthanodieneMargarita E Neganova, Sergey G Klochkov, Sergey A Pukhov, et al.
International Journal of Molecular Sciences|February 13, 2025
Design of New Daunorubicin Derivatives with High Cytotoxic PotentialAleksandra A Kalashnikova, Altynkul B Toibazarova, Oleg I Artyushin, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Medicinal Chemistry|December 21, 2020
The Hydroxamic Acids as Potential Anticancer and Neuroprotective AgentsMargarita E Neganova, Sergey G Klochkov, Yulia R Aleksandrova, et al.
Seminars in Cancer Biology|August 20, 2020
Histone modifications in epigenetic regulation of cancer: Perspectives and achieved progressMargarita E Neganova, Sergey G Klochkov, Yulia R Aleksandrova, et al.
Seminars in Cancer Biology|July 2, 2022
Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disordersMargarita E Neganova, Yulia R Aleksandrova, Olga A Sukocheva, et al.
Bioorganic & Medicinal Chemistry Letters|August 14, 2022
Synthesis and biological testing of 3,5-bis(arylidene)-4-piperidone conjugates with 2,5-dihydro-5H-1,2-oxaphospholenesMargarita E Neganova, Yulia R Aleksandrova, Natalia S Nikolaeva, et al.
Anti-Cancer Agents in Medicinal Chemistry|May 28, 2020
New Spirocyclic Hydroxamic Acids as Effective Antiproliferative AgentsMargarita E Neganova, Sergey G Klochkov, Yulia R Aleksandrova, et al.
Molecules (Basel, Switzerland)|December 11, 2022
Design of Conjugates Based on Sesquiterpene Lactones with Polyalkoxybenzenes by "Click" Chemistry to Create Potential Anticancer AgentsMargarita E Neganova, Ekaterina V Smirnova, Elena V Sharova, et al.
Seminars in Cancer Biology|May 27, 2022
Perspectives of using microRNA-loaded nanocarriers for epigenetic reprogramming of drug resistant colorectal cancersOlga A Sukocheva, Junqi Liu, Margarita E Neganova, et al.
Molecules (Basel, Switzerland)|November 27, 2024
N-Aryl Benzimidazole and Benzotriazole Derivatives and Their Hybrids as Cytotoxic Agents: Design, Synthesis and Structure-Activity Relationship StudiesYulia R Aleksandrova, Natalia S Nikolaeva, Inna A Shagina, et al.
Current Cancer Drug Targets|April 23, 2020
Synthesis and Cytotoxic Activity of Azine Derivatives of 6-HydroxyxanthanodieneMargarita E Neganova, Sergey G Klochkov, Sergey A Pukhov, et al.
International Journal of Molecular Sciences|February 13, 2025
Design of New Daunorubicin Derivatives with High Cytotoxic PotentialAleksandra A Kalashnikova, Altynkul B Toibazarova, Oleg I Artyushin, et al.
Pageof 1